NANOPARTICLES IN SCAFFOLD TISSUE ENGINEERING: DESIGN, FUNCTIONALITY, AND BIOMEDICAL APPLICATION

Abstract

Tissue engineering has emerged as a transformative field in regenerative medicine, seeking to restore or replace damaged tissues and organs through the synergistic combination of biomaterial scaffolds, cells, and bioactive signals. Despite significant advances, conventional scaffolds often fall short in replicating the complex biochemical and biophysical cues of the native extracellular matrix, limiting their therapeutic efficacy. The integration of nanoparticles into scaffold systems has opened new frontiers in addressing these limitations, offering unprecedented control over scaffold architecture, mechanical properties, and biological functionality at the nanoscale. This thesis investigates the multifaceted roles of nanoparticles in scaffold-based tissue engineering, encompassing their design principles, functional contributions, and translational potential. A broad spectrum of nanoparticle types is examined, including metallic, polymeric, ceramic, and carbon-based nanomaterials, each offering distinct physicochemical properties that can be tailored to specific tissue engineering applications. The mechanisms by which nanoparticles enhance scaffold performance are explored in detail, including mechanical reinforcement, controlled and stimuli-responsive delivery of drugs and growth factors, electrical and magnetic stimulation of cell behavior, and inherent antibacterial activity. Tissue-specific applications are critically reviewed across bone, cartilage, neural, cardiac, and dermal systems, highlighting how nanoparticle–scaffold composites promote targeted cellular responses such as osteogenesis, chondrogenesis, neurogenesis, and angiogenesis. Particular attention is given to biocompatibility and nanotoxicology, with a thorough assessment of cytotoxicity mechanisms, inflammatory responses, and current regulatory considerations governing the clinical use of nano-enabled biomaterials. Finally, the thesis addresses persistent challenges in the field, including scalability of fabrication, long term biodegradation behavior, vascularization of engineered constructs, and the gap between laboratory findings and clinical translation. Emerging directions such as 4D bioprinting, AI assisted scaffold design, and personalized nano-scaffold platforms are discussed as promising avenues for the next generation of tissue engineering solutions. Collectively, this work underscores the pivotal role of nanoparticle integration in advancing scaffold tissue engineering toward clinically viable regenerative therapies.